Lista de obras -

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

artículo científico publicado en 2013

A high proportion of founder BRCA1 mutations in Polish breast cancer families

artículo científico publicado en 2004

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

artículo científico publicado en 2006

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

artículo científico publicado en 2004

A survey of preventive measures among BRCA1 mutation carriers from Poland

scientific article published on 01 February 2007

Allelic modification of breast cancer risk in women with an NBN mutation

scientific article published on 13 August 2019

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

artículo científico publicado en 2022

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

artículo científico publicado en 2019

BRCA1 mutations and prostate cancer in Poland

artículo científico publicado en 2008

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer

scientific article published on 29 September 2019

BRCA1-positive breast cancers in young women from Poland.

artículo científico publicado en 2006

Breast cancer (BC) phenotypes in small invasive tumors (pT1a/b pN0).

artículo científico publicado en 2017

Breast cancer predisposing alleles in Poland

artículo científico publicado en 2005

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

artículo científico publicado en 2009

Clinical characteristics of breast cancer in patients with an NBS1 mutation

artículo científico publicado en 2013

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

artículo científico publicado en 2015

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2016

Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2015

Hereditary ovarian cancer in Poland.

artículo científico publicado en 2003

Impact of BRCA1 mutation on survival after early onset breast cancer.

artículo científico publicado en 2012

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

artículo científico publicado en 2019

Inherited variants in XRCC2 and the risk of breast cancer

scientific article published on 28 August 2019

Lynch syndrome mutations shared by the Baltic States and Poland.

artículo científico publicado en 2013

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

artículo científico publicado en 2017

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

artículo científico publicado en 2020

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

artículo científico publicado en 2014

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland.

artículo científico publicado en 2012

New EPCAM founder deletion in Polish population

artículo científico publicado en 2017

PALB2 mutations and prostate cancer risk and survival

artículo científico publicado en 2021

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

artículo científico publicado en 2009

Pathology of breast cancer in women with constitutional CHEK2 mutations

artículo científico publicado en 2005

Patients' Non-Medical and Organizational Needs during Cancer Diagnosis and Treatment

scientific article published on 12 August 2020

Predictors of survival for breast cancer patients with a BRCA1 mutation

artículo científico publicado en 2017

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

artículo científico publicado en 2014

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

artículo científico publicado en 2007

Selenium and the risk of cancer in BRCA1 carriers

artículo científico publicado en 2011

Survival from breast cancer in patients with CHEK2 mutations.

artículo científico publicado en 2014

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer

artículo científico publicado en 2013

The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population

artículo científico publicado en 2023

The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients

artículo científico publicado en 2016

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations

artículo científico publicado en 2022

The spectrum of mutations predisposing to familial breast cancer in Poland

scientific article published on 26 June 2019

Lista de obras de

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

A high proportion of founder BRCA1 mutations in Polish breast cancer families

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

A survey of preventive measures among BRCA1 mutation carriers from Poland

Allelic modification of breast cancer risk in women with an NBN mutation

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

BRCA1 mutations and prostate cancer in Poland

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer

BRCA1-positive breast cancers in young women from Poland.

Breast cancer (BC) phenotypes in small invasive tumors (pT1a/b pN0).

Breast cancer predisposing alleles in Poland

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

Clinical characteristics of breast cancer in patients with an NBS1 mutation

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

Germline RECQL mutations are associated with breast cancer susceptibility

Hereditary ovarian cancer in Poland.

Impact of BRCA1 mutation on survival after early onset breast cancer.

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

Inherited variants in XRCC2 and the risk of breast cancer

Lynch syndrome mutations shared by the Baltic States and Poland.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland.

New EPCAM founder deletion in Polish population

PALB2 mutations and prostate cancer risk and survival

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

Pathology of breast cancer in women with constitutional CHEK2 mutations

Patients' Non-Medical and Organizational Needs during Cancer Diagnosis and Treatment

Predictors of survival for breast cancer patients with a BRCA1 mutation

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

Selenium and the risk of cancer in BRCA1 carriers

Survival from breast cancer in patients with CHEK2 mutations.

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer

The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population

The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations

The spectrum of mutations predisposing to familial breast cancer in Poland